tiprankstipranks
Tissue Regenix Group PLC (GB:TRX)
LSE:TRX

Tissue Regenix (TRX) Share Price & Analysis

8 Followers

TRX Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range48.00p - 72.94p
Previous Close68.5p
Volume44.17K
Average Volume (3M)67.73K
Market Cap
£37.31M
Enterprise Value39.50M
Total Cash (Recent Filing)$5.95M
Total Debt (Recent Filing)$9.61M
Price to Earnings (P/E)-30.5
Beta0.99
Mar 19, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding70,574,468
10 Day Avg. Volume88,179
30 Day Avg. Volume67,733
Standard Deviation0.22
R-Squared0.17
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)3.99
Price to Sales (P/S)337.80
Price to Cash Flow (P/CF)-281431.81
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.61
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

TRX FAQ

What was Tissue Regenix Group PLC’s price range in the past 12 months?
Tissue Regenix Group PLC lowest share price was 48.00p and its highest was 72.94p in the past 12 months.
    What is Tissue Regenix Group PLC’s market cap?
    Currently, no data Available
    When is Tissue Regenix Group PLC’s upcoming earnings report date?
    Tissue Regenix Group PLC’s upcoming earnings report date is Mar 19, 2024 which is 10 days ago.
      How were Tissue Regenix Group PLC’s earnings last quarter?
      Tissue Regenix Group PLC released its earnings results on Sep 05, 2023. The company reported -0.01p earnings per share for the quarter, missing the consensus estimate of N/A by -0.01p.
        Is Tissue Regenix Group PLC overvalued?
        According to Wall Street analysts Tissue Regenix Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Tissue Regenix Group PLC pay dividends?
          Tissue Regenix Group PLC does not currently pay dividends.
          What is Tissue Regenix Group PLC’s EPS estimate?
          Tissue Regenix Group PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Tissue Regenix Group PLC have?
          Tissue Regenix Group PLC has 70,574,470 shares outstanding.
            What happened to Tissue Regenix Group PLC’s price movement after its last earnings report?
            Tissue Regenix Group PLC reported an EPS of -0.01p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7%.
              Which hedge fund is a major shareholder of Tissue Regenix Group PLC?
              Currently, no hedge funds are holding shares in GB:TRX
              ---

              Tissue Regenix Stock Smart Score

              5
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              14.16%
              12-Months-Change

              Fundamentals

              Return on Equity
              -6.56%
              Trailing 12-Months
              Asset Growth
              -3.50%
              Trailing 12-Months

              Company Description

              Tissue Regenix Group PLC

              Tissue Regenix Group PLC is a player in the field of biotechnology. It is a medical technology company engaged in the development of regenerative products. The company incorporates dcell technology, which helps to address complex and varying clinical needs. The company has operations worldwide, with special emphasis in the United States.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              HUTCHMED (China) Limited
              Alliance Pharma
              Genedrive
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis